Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.
3.

Factors in the assessment of suicidality in youth.

Posner K, Melvin GA, Stanley B, Oquendo MA, Gould M.

CNS Spectr. 2007 Feb;12(2):156-62.

4.

Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.

DeVeaugh-Geiss J, March J, Shapiro M, Andreason PJ, Emslie G, Ford LM, Greenhill L, Murphy D, Prentice E, Roberts R, Silva S, Swanson JM, van Zwieten-Boot B, Vitiello B, Wagner KD, Mangum B.

J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):261-70.

PMID:
16540810
5.

Translational and clinical science--time for a new vision.

Zerhouni EA.

N Engl J Med. 2005 Oct 13;353(15):1621-3. Epub 2005 Oct 12. No abstract available.

6.

The case for practical clinical trials in psychiatry.

March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R.

Am J Psychiatry. 2005 May;162(5):836-46.

PMID:
15863782
7.

The Health of the Nation Outcome Scales for Children and Adolescents in an adolescent in-patient sample.

Harnett PH, Loxton NJ, Sadler T, Hides L, Baldwin A.

Aust N Z J Psychiatry. 2005 Mar;39(3):129-35.

PMID:
15701060
8.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
9.

The Child and Adolescent Psychiatry Trials Network (CAPTN).

March JS, Silva SG, Compton S, Anthony G, DeVeaugh-Geiss J, Califf R, Krishnan R.

J Am Acad Child Adolesc Psychiatry. 2004 May;43(5):515-8.

PMID:
15100557
10.

Medicine. The NIH Roadmap.

Zerhouni E.

Science. 2003 Oct 3;302(5642):63-72.

PMID:
14526066
11.
12.

How can we improve the assessment of safety in child and adolescent psychopharmacology?

Vitiello B, Riddle MA, Greenhill LL, March JS, Levine J, Schachar RJ, Abikoff H, Zito JM, McCracken JT, Walkup JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Capasso L.

J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):634-41. Review.

PMID:
12921470
13.

Review of safety assessment methods used in pediatric psychopharmacology.

Greenhill LL, Vitiello B, Riddle MA, Fisher P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM, McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L, Rosengarten J.

J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):627-33. Review.

PMID:
12921469
14.

Assessment of safety in pediatric psychopharmacology.

Greenhill LL.

J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):625-6. No abstract available.

PMID:
12921468
15.

Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.

Treatment for Adolescents With Depression Study Team.

J Am Acad Child Adolesc Psychiatry. 2003 May;42(5):531-42.

PMID:
12707557
16.

Lessons learned from recent cardiovascular clinical trials: Part II.

DeMets DL, Califf RM.

Circulation. 2002 Aug 13;106(7):880-6. Review. No abstract available.

17.

Lessons learned from recent cardiovascular clinical trials: Part I.

DeMets DL, Califf RM.

Circulation. 2002 Aug 6;106(6):746-51. Review. No abstract available.

18.
20.

Child and adolescent mental health service use. HoNOSCA as an outcome measure.

Garralda ME, Yates P, Higginson I.

Br J Psychiatry. 2000 Jul;177:52-8.

Supplemental Content

Support Center